Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics
Article first published online: 20 JAN 2013
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd
Pediatric Allergy and Immunology
Volume 24, Issue 1, pages 49–53, February 2013
How to Cite
Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics. Pediatr Allergy Immunol 2013: 24: 49–53..
- Issue published online: 20 JAN 2013
- Article first published online: 20 JAN 2013
- Manuscript Accepted: 22 OCT 2012
- 4Improved quality of life, immunoglobulin G levels, and infection rate in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G. South Med J 2010: 103: 856–63., , , et al.
- 9American Academy of Allergy, Asthma and Immunology. Position statement on the appropriate use of intravenously administered immunoglobulin (IGIV). January 2005. Available at: http://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/IGIV-2005.pdf. Accessed September 25, 2012.
- 10Vivaglobin Prescribing Information. Marburg, Germany: CSL Behring GmbH, 2010.
- 11Hizentra [package insert]. Bern, Switzerland: CSL Behring AG, 2011.
- 12European Agency for the Evaluation of Medicinal Products (EMEA), Committee for Proprietary Medicinal Products (CPMP). Note for guidance on the clinical investigation of human normal immunoglobulin for subcutaneous and intramuscular use, 2002. EMEA/CPMP/BPWG/282/00. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004255.pdf. Accessed May 14, 2012.
- 18Factors affecting infusion of high (20%) vs. lower concentration (16%) SCIg in primary immunodeficiency disorders [abstract]. Annual Meeting of the American Academy of Allergy Asthma & Immunology; Orlando, FL, March 2-6, 2012., .